Bites - Management of Infection Guidance for Primary Care

Publication: 30/09/2010  --
Last review: 11/03/2022  
Next review: 11/03/2023  
Clinical Guideline
UNDER REVIEW 
ID: 2259 
Approved By:  
Copyright© Leeds Teaching Hospitals NHS Trust 2022  

 

This Clinical Guideline is intended for use by healthcare professionals within Leeds unless otherwise stated.
For healthcare professionals in other trusts, please ensure that you consult relevant local and national guidance.

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee has recommended restricting the use of fluoroquinolone antibiotics following a review of disabling and potentially long-lasting side effects mainly involving muscles, tendons, bones and the nervous system. This includes a recommendation not to use them for mild or moderately severe infections unless other antibiotics cannot be used (MHRA advice November 2018).

Bites - human and animal

The previous version of this guideline is being reviewed. In the meantime, please refer to NICE guidance :
Human and animal bites: antimicrobial prescribing NG 184
visual-summary-pdf-8897023117 (nice.org.uk)
Overview | Human and animal bites: antimicrobial prescribing | Guidance | NICE

Provenance

Record: 2259
Objective:
Clinical condition:

Bites

Target patient group:
Target professional group(s): Primary Care Doctors
Pharmacists
Adapted from:

Evidence base

Document history

LHP version 1.0

Related information

Not supplied